Fecal Microbiota Transplantation & Clostridium difficile & Pseudomembraneceus colitis
Fecal Microbiota Transplantation.
Fecal Microbiota Transplantation for Primary Clostridium difficile Infection.
Fecal microbiota transplantation: Review and update.
Fecal Microbiota Transplantation Is Superior to Fidaxomicin for Treatment of Recurrent Clostridium difficile Infection.
Clostridium difficile infection: review.
Effect of Fecal Microbiota Transplantation on Recurrence in Multiply Recurrent Clostridium difficile Infection: A Randomized Trial.
Clostridium difficile Infection and Fecal Microbiota Transplant.
Fecal microbiota transplantation in the treatment of Clostridium difficile infection: state of the art and literature review.
Fecal microbiota transplantation (FMT) for C. difficile infection, just say 'No'.
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection and Other Conditions in Children: A Joint Position Paper From the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the European Society for Pediatric Gastroenterology, Hepatology, and Nutrition.
Fecal microbiota transplantation in cancer management: Current status and perspectives.
Fecal microbiota transplantation: past, present and future perspectives.
Fecal microbiota transplantation for recurrent clostridium difficile infection in children.
Fecal microbiota transplantation in ulcerative colitis.
Clinical Application and Potential of Fecal Microbiota Transplantation.
Expert opinion on fecal microbiota transplantation for the treatment of Clostridioides difficile infection and beyond.
Fecal microbiota transplantation beyond Clostridioides difficile infections.
Clostridium difficile.
Are There Potential Applications of Fecal Microbiota Transplantation beyond Intestinal Disorders?
Fecal microbiota transplantation - methods of treatment of recurrent Clostridium difficile infections and other diseases.
Fecal Microbiota Transplantation for Clostridium difficile-Associated Diarrhea.
Clostridium difficile Colitis Prevention and Treatment.
Clostridium difficile colitis: pathogenesis and host defence.
Nuts and Bolts of Fecal Microbiota Transplantation.
Fecal microbiota transplantation for Clostridium difficile infection: back to the future.
Update of treatment algorithms for Clostridium difficile infection.
Clostridioides difficile: diagnosis and treatments.
Current Evidence in Delivery and Therapeutic Uses of Fecal Microbiota Transplantation in Human Diseases-Clostridium difficile Disease and Beyond.
Fecal Microbiota Transplantation for Clostridium difficile Infection: A One-Center Experience.
Safety and efficacy of encapsulated fecal microbiota transplantation for recurrent Clostridium difficile infection: a systematic review.
Fecal microbiota transplantation for the treatment of patients with ulcerative colitis and other gastrointestinal conditions beyond Clostridium difficile infection: an update.
Systematic review with meta-analysis: the efficacy of faecal microbiota transplantation for the treatment of recurrent and refractory Clostridium difficile infection.
Fecal microbiota transplantation for the treatment of Clostridium difficile infection.
Fecal microbiota transplantation for recurrent Clostridium difficile infection.
Reducing Cost and Complexity of Fecal Microbiota Transplantation Using Universal Donors for Recurrent Clostridium difficile Infection.
Laboratory Testing of Donors and Stool Samples for Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection.
Fecal microbiota transplantation for recurrent Clostridium difficile infection in patients with solid organ transplants: an institutional experience and review of the literature.
Fecal Microbiota Transplantation for Clostridium difficile Infection: A Systematic Review.
Probiotics for prevention of Clostridium difficile infection.
Clostridium difficile infection and antibiotic-associated diarrhoea.
Durable Long-Term Bacterial Engraftment following Encapsulated Fecal Microbiota Transplantation To Treat Clostridium difficile Infection.
The Super-Donor Phenomenon in Fecal Microbiota Transplantation.
Clostridium difficile cure with fecal microbiota transplantation in a child with Pompe disease: a case report.
Fecal Microbiota Transplantation for Recurrent Clostridioides difficile infection: The COVID-19 Era.
The 5D framework: a clinical primer for fecal microbiota transplantation to treat Clostridium difficile infection.
Fecal microbiota transplantation for recurrent Clostridium difficile infection: Experience, protocol, and results.
Fecal Microbial Transplantation impact on gut microbiota composition and metabolome, microbial translocation and T-lymphocyte immune activation in recurrent Clostridium difficile infection patients.
Early Fecal Microbiota Transplantation Improves Survival in Severe Clostridium difficile Infections.
Randomised clinical trial: faecal microbiota transplantation by colonoscopy plus vancomycin for the treatment of severe refractory Clostridium difficile infection-single versus multiple infusions.
Recurrent Clostridium difficile Infection: Risk Factors, Treatment, and Prevention.
Successful Resolution of Recurrent Clostridium difficile Infection using Freeze-Dried, Encapsulated Fecal Microbiota; Pragmatic Cohort Study.
Fecal microbiota transplantation in children: current concepts.
THE POWER OF POOP: FECAL MICROBIOTA TRANSPLANTATION FOR CLOSTRIDIUM DIFFICILE INFECTION.
Is frozen fecal microbiota transplantation as effective as fresh fecal microbiota transplantation in patients with recurrent or refractory Clostridium difficile infection: A meta-analysis?
[Fecal microbiota transplantation, a novel therapy for recurrent Clostridium difficile infection].
Safety and preliminary efficacy of orally administered lyophilized fecal microbiota product compared with frozen product given by enema for recurrent Clostridium difficile infection: A randomized clinical trial.
Frozen vs Fresh Fecal Microbiota Transplantation and Clinical Resolution of Diarrhea in Patients With Recurrent Clostridium difficile Infection: A Randomized Clinical Trial.
A network meta-analysis of randomized controlled trials exploring the role of fecal microbiota transplantation in recurrent Clostridium difficile infection.
Predicting recurrence of Clostridium difficile infection following encapsulated fecal microbiota transplantation.
[Fecal microbiota transplantation through colonoscopy for Clostridium difficile recurrent infection. Report of eight cases].
European consensus conference on faecal microbiota transplantation in clinical practice.
Is fecal microbiota transplantation a temporary patch for treatment of Clostridium difficile infection or a new frontier of therapeutics?
Upper Versus Lower Gastrointestinal Delivery for Transplantation of Fecal Microbiota in Recurrent or Refractory Clostridium difficile Infection: A Collaborative Analysis of Individual Patient Data From 14 Studies.
Fecal microbiota transplantation as a new therapy: from Clostridioides difficile infection to inflammatory bowel disease, irritable bowel syndrome, and colon cancer.
[Fecal microbiota transplantation in recurrent Clostridium difficile infections. Framework and pharmaceutical preparation aspects].
Fecal microbiota transplantation for the treatment of Clostridium difficile infection: a systematic review.
Commercialized fecal microbiota transplantation provides efficacious treatment of Clostridium difficile infection.
Microbiota transplantation: concept, methodology and strategy for its modernization.
Fecal Microbiota Transplantation in Clostridium difficile Infection: Evidence and Indications.
Fecal Microbiota Therapy for Clostridium difficile Infection: A Health Technology Assessment.
Fecal microbiota transplantation for the management of Clostridium difficile infection.
Fecal Microbiota Transplantation for Chronic Liver Diseases: Current Understanding and Future Direction.
Understanding the mechanisms of faecal microbiota transplantation.
Fecal Fixation: Fecal Microbiota Transplantation for Clostridium difficile Infection.
Fecal microbiota transplantation in refractory or recurrent Clostridium difficile infection: a real-life experience in a non-academic center.
Incidence of Bloodstream Infections, Length of Hospital Stay, and Survival in Patients With Recurrent Clostridioides difficile Infection Treated With Fecal Microbiota Transplantation or Antibiotics: A Prospective Cohort Study.
Update on Fecal Microbiota Transplantation 2015: Indications, Methodologies, Mechanisms, and Outlook.
[Fecal microbiota transplantation: indications and perspectives].
[Fecal microbiota transplantation in relapsing clostridium difficile colitis].
Outcomes of Fecal Microbiota Transplantation for Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Concomitant resolution through fecal microbiota transplantation of Clostridium difficile and OXA-48-producing Klebsiella pneumoniae.
Fecal microbiota transplantation in recurrent Clostridium difficile infection in a patient with concomitant inflammatory bowel disease.
Successful therapy of Clostridium difficile infection with fecal microbiota transplantation.
Fecal microbiota transplantation for recurrent Clostridioides difficile infection.
Fecal microbiota transplantation: standardization or diversification?
The Use and Efficacy of Fecal Microbiota Transplantation for Refractory Clostridium difficile in Patients with Inflammatory Bowel Disease.
Fecal microbiota transplantation (FMT) for Clostridium difficile infection: focus on immunocompromised patients.
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection Reduces Recurrent Urinary Tract Infection Frequency.
Fecal microbiota transplant in patients with Clostridium difficile infection: A systematic review.
Comparing fecal microbiota transplantation to standard-of-care treatment for recurrent Clostridium difficile infection: a systematic review and meta-analysis.
Fecal Microbiota Transplantation Eliminates Clostridium difficile in a Murine Model of Relapsing Disease.
A Systematic Review of the Efficacy and Safety of Fecal Microbiota Transplant for Clostridium difficile Infection in Immunocompromised Patients.
Fecal microbiota transplantation for the treatment of recurrent and severe Clostridium difficile infection in solid organ transplant recipients: A multicenter experience.
Fecal Microbiota Transfer.
Clostridium difficile Infection.
Efficacy of Sterile Fecal Filtrate Transfer for Treating Patients With Clostridium difficile Infection.
Oral Vancomycin Followed by Fecal Transplantation Versus Tapering Oral Vancomycin Treatment for Recurrent Clostridium difficile Infection: An Open-Label, Randomized Controlled Trial.
Capsules for Fecal Microbiota Transplantation in Recurrent Clostridium difficile Infection: The New Way Forward or a Tough Pill to Swallow?
Fecal Microbiota Transplantation Capsules with Targeted Colonic Versus Gastric Delivery in Recurrent Clostridium difficile Infection: A Comparative Cohort Analysis of High and Lose Dose.
Longitudinal microbiome analysis of single donor fecal microbiota transplantation in patients with recurrent Clostridium difficile infection and/or ulcerative colitis.
Risk Factors for Gastrointestinal Symptoms Following Successful Eradication of Clostridium difficile by Fecal Microbiota Transplantation (FMT).
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infection in the Elderly: Long-Term Outcomes and Microbiota Changes.
Current applications of fecal microbiota transplantation in intestinal disorders.
Mini-Fecal Microbiota Transplantation for Treatment of Clostridium difficile Proctitis Following Total Colectomy.
Analysis of Treatment Outcomes for Recurrent Clostridium difficile Infections and Fecal Microbiota Transplantation in a Pediatric Hospital.
[Customised infectiology - Fecal microbiota transplantation : following the Clostridioides difficile pathway].
A repeat offender: Recurrent extraintestinal Clostridium difficile infection following fecal microbiota transplantation.
Fecal Microbiota Transplant for Clostridium difficile Infection in a Pregnant Patient.
The gut microbiome.
Fecal microbiota transplantation for severe clostridium difficile infection after left ventricular assist device implantation: a case control study and concise review on the local and regional therapies.
Fecal microbiota transplantation and emerging treatments for Clostridium difficile infection.
Cost-effectiveness analysis of ribotype-guided fecal microbiota transplantation in Chinese patients with severe Clostridium difficile infection.
[Refractory colitis by Clostridium difficile treated with fecal microbiota transplant].
How to Manipulate the Microbiota: Fecal Microbiota Transplantation.
[Intestinal microbiota and allogeneic stem cell transplantation].
Regulatory Considerations for Fecal Microbiota Transplantation Products.
Intestinal Microbiome Changes in Fecal Microbiota Transplant (FMT) vs. FMT Enriched with Lactobacillus in the Treatment of Recurrent Clostridioides difficile Infection.
Gut fungal dysbiosis correlates with reduced efficacy of fecal microbiota transplantation in Clostridium difficile infection.
[Practice and consideration of fecal microbiota transplantation].
Fecal microbiota transplantation for recurrent Clostridium difficile infection: The patient experience.
Editorial: Making Fecal Microbiota Transplantation Easier to Swallow: Freeze-Dried Preparation for Recurrent Clostridium difficile Infections.
An Intragastric Fecal Microbiota Transplantation Program for Treatment of Recurrent Clostridium difficile in Children is Efficacious, Safe, and Inexpensive.
[Practical clues for a fecal microbiota transplantation by colonoscopy for recurrent Clostridium difficile infection. Experience in a University center].
Therapies to modulate gut microbiota: Past, present and future.
Donor Considerations in Fecal Microbiota Transplantation.
Non-invasive fecal microbiota transplantation for recurrent Clostridium difficile infection in a patient presenting with hypertensive disorder post interventionem.
Treating Clostridium difficile infection with fecal microbiota transplantation.
Fecal Microbiota Transplantation: Current Status in Treatment of GI and Liver Disease.
The use of faecal microbiota transplant as treatment for recurrent or refractory Clostridium difficile infection and other potential indications: joint British Society of Gastroenterology (BSG) and Healthcare Infection Society (HIS) guidelines.
Fecal Microbiota Transplantation for Recurrent Clostridium difficile Infections in Pediatric Hematopoietic Stem Cell Transplant Recipients.
The microbiota and immune response during Clostridium difficile infection.
Economic evaluation of fecal microbiota transplantation for the treatment of recurrent Clostridium difficile infection in Australia.
Strain Tracking Reveals the Determinants of Bacterial Engraftment in the Human Gut Following Fecal Microbiota Transplantation.
The Route to Palatable Fecal Microbiota Transplantation.
Successful treatment by fecal microbiota transplantation for Japanese patients with refractory Clostridium difficile infection: A prospective case series.
Clostridioides difficile (formerly Clostridium difficile) infection in the critically ill: an expert statement.
Faecal Microbiota Transplantation for Clostridium Difficile - a local perspective.
Is it reasonable to perform Fecal Microbiota Transplantation for recurrent Clostridium difficile Infection in patients with liver cirrhosis?
Fecal Microbiota-based Therapeutics for Recurrent Clostridium difficile Infection, Ulcerative Colitis and Obesity.
Fecal microbiota transplantation for recurrent Clostridium difficile infection in hematopoietic stem cell transplant recipients.
Fecal Microbiota Transplantation: An Ambiguous Translational Pathway for a Promising Treatment.
Long-term microbiota and virome in a Zurich patient after fecal transplantation against Clostridium difficile infection.
Fecal microbiota transplantation for hepatic encephalopathy: Ready for prime time?
Diagnosis and Treatment of Clostridium difficile Infection.
Just another crappy commentary: the future of fecal microbiota transplantation.
[Experience with fecal transplantation in the treatment of Clostridium difficile infection].
Systematic review with meta-analysis: long-term outcomes of faecal microbiota transplantation for Clostridium difficile infection.
Expanded Evidence for Frozen Fecal Microbiota Transplantation for Clostridium difficile Infection: A Fresh Take.
[Future perspectives on fecal microbiota transplantation].
Fidaxomicin and Fecal Microbiota Transplants for Severe Clostridium difficile Colitis.
Microbial Engraftment and Efficacy of Fecal Microbiota Transplant for Clostridium Difficile in Patients With and Without Inflammatory Bowel Disease.
International consensus conference on stool banking for faecal microbiota transplantation in clinical practice.
Fecal Microbiota Transplant: Treatment Options for Clostridium difficile Infection in the Intensive Care Unit.
Faecal microbiota transplantation for recurrent Clostridium difficile infection and beyond: risks and regulation.
Ninety-eight years old female successfully successfully treated with fecal microbiota transplantation after recurrent Clostridium difficile infection.
Fecal Microbiota Transplantation: Do We Need Harmonization?
Vancomycin Taper and Risk of Failure of Fecal Microbiota Transplantation in Patients With Recurrent Clostridium difficile Infection.
[Faecal microbiota transplantation for Clostridioides difficile infection].
Oral faecal microbiota transplantation for the treatment of Clostridium difficile-associated diarrhoea in a dog: a case report.
2019 update of the WSES guidelines for management of Clostridioides (Clostridium) difficile infection in surgical patients.
Bezlotoxumab for Prevention of Recurrent Clostridium difficile Infection in Patients at Increased Risk for Recurrence.
[Fecal microbiota transplantation].
Fecal Microbiota Transplantation and Urinary Tract Infection: An Interesting Approach.
Abnormal Intestinal Microbiome in Medical Disorders and Potential Reversibility by Fecal Microbiota Transplantation.
Faecal microbiota transplantation for Clostridium difficile associated diarrhoea: a systematic review of randomised controlled trials.
Dramatic reduction in Clostridium difficile ribotype 027-associated mortality with early fecal transplantation by the nasogastric route: a preliminary report.
Effective fecal microbiota transplantation for recurrent Clostridioides difficile infection in humans is associated with increased signalling in the bile acid-farnesoid X receptor-fibroblast growth factor pathway.
Fecal Microbiota Transplantation in Inflammatory Bowel Disease: A Primer for Internists.
Fecal Transplantation for Clostridium Difficile-"All Stool May Not Be Created Equal".
Update on Treatment of Clostridioides difficile Infection.
Fecal microbiota transplantation donation: the gift that keeps on giving.
Fecal microbiota transplant for C. difficile infection: Just say yes.
Oral fecal microbiota transplant for recurrent Clostridium difficile in pediatric autoimmune enteropathy.
Clostridium difficile in Immunocompromised Hosts: A Review of Epidemiology, Risk Factors, Treatment, and Prevention.
Process and Outcome of Fecal Microbiota Transplants in Patients With Recurrent Clostridium difficile Infection: A Prospective Study.
[Fecal microbiota transplantation: review].
Review of the emerging treatment of Clostridium difficile infection with fecal microbiota transplantation and insights into future challenges.
Fecal Microbiota Transplantation: Just a Fancy Trend?
The success of fecal microbial transplantation in Clostridium difficile infection correlates with bacteriophage relative abundance in the donor: a retrospective cohort study.
Donor Screening Experience for Fecal Microbiota Transplantation in Patients With Recurrent C. difficile Infection.
Faecal microbiota transplantation for <em>Clostridium difficile</em> infection: a multicentre study of non-responders.
Diarrhea after fecal microbiota transplantation for recurrent Clostridioides difficile infection.
Fecal microbiota transplantation in gastrointestinal disease: 2015 update and the road ahead.
An Infectious Diseases Perspective on Fecal Microbiota Transplantation for Clostridioides difficile Infection in Children.
Fecal Microbiota Transplantation: Restoring the Injured Microbiome after Allogeneic Hematopoietic Cell Transplantation.
Fecal Transplantation for Treatment of Clostridium Difficile Infection in Elderly and Debilitated Patients.
A Practical Method for Preparation of Fecal Microbiota Transplantation.
[Fecal microbiota transplantation therapy for patients with gastrointestinal tract diseases].
[Indication selection and clinical application strategies of fecal microbiota transplantation].
Fecal Microbiota Transplantation is Safe and Efficacious for Recurrent or Refractory Clostridium difficile Infection in Patients with Inflammatory Bowel Disease.
Asymptomatic Clostridium difficile carriage rate post-fecal microbiota transplant is low: a prospective clinical and stool assessment.
Oral, frozen fecal microbiota transplant (FMT) capsules for recurrent Clostridium difficile infection.
Celiac Disease and Fecal Microbiota Transplantation: A New Beginning?
Faecal microbiota transplantation in recurrent Clostridium difficile infection: Recommendations from the French Group of Faecal microbiota Transplantation.
Editorial: faecal microbiota transplantation-the silver bullet for severe and fulminant Clostridioides difficile infection?
Transplanting Fecal Virus-Like Particles Reduces High-Fat Diet-Induced Small Intestinal Bacterial Overgrowth in Mice.
An ecological framework to understand the efficacy of fecal microbiota transplantation.
Probiotics and Fecal Microbiota Transplant for Primary and Secondary Prevention of Clostridium difficile Infection.
Emerging drugs for the treatment of clostridium difficile.
[Fecal microbiota transplantation in recurrent Clostridium difficile infection. Report of one case].
Effect of Faecal Microbiota Transplantation for Treatment of Clostridium difficile Infection in Patients With Inflammatory Bowel Disease: A Systematic Review and Meta-Analysis of Cohort Studies.